RAC is well positioned, great communication from management, RC 220 was a major leap forward, seems toxicity is also going well so far. Moreover, the whole biotech sector is hot. From a historical perspective I think RAC is undervalued. That’s why I invest in this company and I believe the share price will increase. One drawback is that the stock is not very liquid so if you want to trade this is not the best stock. If you bought with a long term view share price movements don’t matter.
RAC - Charts & Price Action, page-20634
-
- There are more pages in this discussion • 946 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |